Articles tagged with Sars Cov 2
Researchers at the Indian Institute of Science have discovered picolinic acid's ability to disrupt viral entry into host cells, blocking enveloped viruses like SARS-CoV-2 and influenza A viruses. The compound targets a host-derived component of the virus, causing permanent damage while minimizing effects on the host cell.
The Omicron subvariant BA.5 efficiently infects lung cells due to a mutation in the spike protein, enabling efficient entry and fusion with lung cells. This finding suggests that future SARS-CoV-2 variants may regain the ability to cause severe illness in risk patients and people with insufficient immunity.
A survey of 2,000 German adults found that people with higher levels of empathy and cosmopolitanism are more likely to prioritize sharing vaccine supplies internationally. The study suggests that there is substantial public support for international vaccine solidarity when infection rates are at a modest level and falling.
Researchers created a real-time air monitor that can detect SARS-CoV-2 variants in about 5 minutes, with potential applications for hospitals, schools, and public places. The device uses an ultrasensitive biosensing technique and aerosol sampling technology to quickly identify airborne virus concentrations.
The decision analytic model found monoclonal antibodies pre-exposure prophylaxis to be cost-effective for individuals at increased risk of severe COVID-19. The study suggests that lower drug prices and higher effectiveness could further increase the benefits of mAbs PrEP provision.
A new study suggests that wastewater monitoring can be an effective way to track the spread of infectious diseases. The research found that testing for COVID-19 in wastewater was an objective way to measure where the disease was spreading, with most samples processed in under four days.
The Midwest AViDD Center has awarded $3 million in funding for six high-potential antiviral drug discovery projects targeting pandemic viruses such as SARS-CoV-2, Lassa and Ebola. These projects will expand the Center's expertise across disciplines to discover effective responses to pandemics and life-threatening infections.
A new Boston University study found that COVID vaccines likely do not affect menstrual cycle regularity, bleed length, or pain. Menstrual cycles increased by 1.1 days after a first dose and 1.3 days after a second, but these changes resolved within one to two cycles.
A study of commercially insured adults with chronic noncancer pain found that state medical cannabis laws did not lead to a reduction in the use of opioid or nonopioid pain treatments. The researchers also suggested slow implementation and reluctance among healthcare leaders may have contributed to these findings.
A new mRNA vaccine, SYS6006, was evaluated for its safety and immunogenicity as a fourth-dose booster in healthy Chinese adults. The study found that the vaccine elicited higher titers of antibodies against Omicron variants compared to convalescent patients.
A prospective study of COVID-19 mRNA vaccines found progressively declining immune functions in individuals with chronic lymphocytic leukemia (CLL). The study, published in PLOS Medicine, showed that CLL patients experienced reduced antibody responses to the vaccines.
Researchers found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity, with higher levels of antibodies promoting neutralization. The study suggests targeting the S2 region for intranasal vaccines may increase nasal mucosal levels of IgA and viral neutralization.
Researchers have identified four species of coronaviruses in UK bats, including two novel ones, which are related to COVID-19 and MERS viruses. Regular monitoring of wildlife viruses is crucial for public health preparedness and biodiversity conservation.
A study published in Blood reveals that SARS-CoV-2 prefers to infect blood group A cells, increasing the risk of infection. The Omicron strain of the virus also shows a stronger preference for A cells.
Scientists at the University of Cambridge identified a signature in the blood that could predict how well an individual responds to vaccines. They found that those with higher levels of age-associated B cells are less effective after vaccination.
Researchers identified four therapeutic monoclonal antibody candidates that neutralized a range of SARS-CoV-2 variants. Prolonged exposure to the virus triggered somatic hypermutations, equipping these antibodies with an extensive binding interface.
New study finds that men who suffered from mild COVID-19 have lower sperm concentrations and motility even three months after recovery. The researchers believe that the virus may cause permanent damage to male fertility, leading to long-term decline in semen quality.
Peruvoside has been discovered to prevent up to 12 medically important viruses, including SARS-CoV-2, Hand, Foot and Mouth Disease (HFMD), and Influenza. The compound acts on GBF1 protein, disabling its functionality and stopping virus production.
Researchers establish a direct link between Covid-19 and Alzheimer's disease, attributing the connection to RAS overactivation caused by SARS-CoV-2 virus. This dysfunction leads to increased b-amyloid protein accumulation, impairing brain cell synaptic connections and cognitive functions.
Researchers at NYU Abu Dhabi have developed an innovative adhesive bandage that can quickly detect COVID-19 antibodies in the bloodstream. The test uses gold nanoparticles to recognize and bind to IgM and IgG antibodies, providing users with critical information about their immune response to the infection.
Researchers at the University of Bristol found that viruses lose their infectivity quicker in cleaner air, with opening a window reducing acid content and speeding up death. The study provides valuable insights into mitigating risk through gas composition manipulation.
A recent study unveiled the doorway that SARS-CoV2 uses to slip inside cells undetected. Cholesterol clusters make up this door, allowing the virus to infect human cells. Regular exercise and mechanical force can disrupt these cholesterol aggregates, reducing the risk of infection.
Researchers from Tokyo Medical and Dental University found that apple-shaped obesity is associated with cytokine storm and a higher risk of death in COVID-19 patients. The study suggests that obese patients with excess belly fat may benefit from anti-inflammatory therapies, including IL-6 blockers.
Researchers found a link between short telomeres in ATII cells and lung fibrosis in post-COVID-19 patients. The study revealed loss of ATII cellularity and shorter telomeres concomitant with increased fibrotic lung parenchyma remodeling.
Researchers used infected stem cells to study COVID-19's impact on organs, identifying effective anti-viral drugs for treatment. The study found distinct antiviral profiles in heart and lungs, paving the way for new therapeutic options.
Researchers have identified DYRK1A as a key regulator of the SARS-CoV-2 viral receptor, which is critical for entry into human tissues. Reducing DYRK1A activity decreases infection, providing new insights into COVID-19 causation and potential antiviral treatments.
Researchers found that coronaviruses, like SARS-CoV-2, bind to individual monomeric ACE2 receptors on host cells, rather than forming dimers or oligomers. This interaction is sufficient for infection and contributes to the virus's high infectiousness.
A recent study has found that long COVID patients experience a chronic inflammatory response, similar to autoimmune diseases. The researchers identified specific molecular markers associated with this condition, which could help guide clinical trial and treatment decisions. Understanding the underlying inflammation is crucial for devel...
A retrospective analysis of national data found that over 20 million Americans experienced loss of smell or taste after COVID infection, with a large portion never fully recovering these senses. The study estimated that almost 28 million Americans may be left with decreased sense of smell after COVID infection.
A new study reveals a previously unknown way the immune system detects certain viruses, including SARS-Cov-2, using the inflammasome protein CARD8. Researchers found that CARD8 functions differently among various species and even varies between individuals in the human population.
A new randomized controlled trial found that taking metformin after testing positive for SARS-CoV-2 reduces the risk of developing long COVID by 40%. The study, published in The Lancet Infectious Diseases, involved over 1,100 patients and showed metformin prevented over 40% of cases of long COVID over a 10-month follow-up period.
Two studies investigate long-term consequences of COVID-19, identifying potential drug targets for treating chronic disease. Researchers found novel pathways in the lungs and immune system that may lead to effective treatment options, including therapies targeting immune dysfunction and mucous cell differentiation.
Researchers found that lymphoid depletion lesions in the spleen of SARS-CoV2-infected mice may trigger novel therapies to restore defective antigen-presenting cell functions in humans. The severity of COVID-19 varies significantly, with dysregulated immune responses linked to poor outcomes.
Researchers at La Jolla Institute for Immunology have found that T cells can recognize shared viral targets between multiple coronaviruses, including common cold coronaviruses and SARS-CoV-2. This cross-reactivity could be harnessed to develop vaccines that protect against multiple types of coronaviruses, including SARS-CoV-2.
A new study published in Microbiology Spectrum found that cats are susceptible to SARS-CoV-2 and can spread the virus to other cats and their environment. The infected cats' environments were also found to be infectious, but this infectiousness decays rapidly.
A team at Penn State has produced high-resolution images of SARS-CoV-2's protease protein and polyprotein complex. The research reveals a consistent order in which the proteins are cleaved, potentially supporting more efficient antiviral drugs.
A study by University of Córdoba found that people coinfected with SARS-CoV-2 and cytomegalovirus are at increased risk of developing cardiovascular disease due to premature aging of their immune systems. This risk is higher in individuals who have been vaccinated against COVID-19.
A study of 1,979 women found that healthy sleep prior to and during the COVID-19 pandemic may protect against post-COVID condition. Researchers suggest interventions on sleep health could prevent or alleviate long COVID symptoms.
A large study of nearly 10,000 Americans with COVID-19 has uncovered the most common symptoms and potential subgroups associated with long COVID. The research team identified 12 key symptoms that distinguish those with and without long COVID, as well as a scoring system to diagnose and monitor patients.
Researchers identified 37 symptoms across multiple pathophysiological domains that are more common in SARS-CoV-2 infected participants at six months post-infection. A preliminary rule for identifying postacute sequelae of SARS-CoV-2 infection (Long COVID) was derived from a composite symptom score and requires further refinement.
Researchers analyzed hospitalization and fatality rates of SARS-CoV-2 infection in England between May 2020 and March 2022. The study found that the mass vaccination campaign significantly reduced severe effects of the virus, with notable improvements after the emergence of Alpha, Delta, and Omicron variants.
A nationwide study of nearly 10,000 adults identifies 12 hallmarks of long COVID, including debilitating fatigue, loss of smell or taste, and gastrointestinal symptoms. The findings provide a new scoring system for clinicians to define and investigate treatments for patients with long COVID.
Research reveals that chronic heart rate failure during exercise is a common reason for long-term exercise intolerance in Long COVID patients. The study also found a correlation between early post-COVID inflammation biomarkers and reduced exercise capacity, suggesting potential therapeutic targets.
Immunoglobin G and neutralizing antibody titer levels associated with protection against Omicron variant infection and symptomatic disease in vaccinated health care workers. A study of 2,300 healthcare workers found higher antibody levels reduced the risk of infection and disease.
A study found that children with COVID-19 were 57% more likely to develop type 1 diabetes, with the increase occurring shortly after the virus diagnosis. The researchers hope to explore this correlation further using prospective cohorts of children.
Researchers have found that honokiol, a compound from magnolia tree bark, inhibits SARS-CoV-2 replication in several cell types, reducing infectious particle production. The compound also shows broad-spectrum activity against other highly pathogenic coronaviruses.
A new study shows that masking and portable air cleaners significantly reduced the spread of SARS-CoV-2 in two Swiss schools during the Omicron wave. The researchers detected salivary and airborne virus concentrations in air samples and students, with a 70% decrease in viral transmission under mask mandates.
A recent study found that COVID-19 infection can lead to increased infarct growth and ongoing tissue consumption even after successful reperfusion through angiography. This suggests a potentially aggressive clinical course for patients with COVID-19 and large-vessel occlusion acute ischemic stroke.
A large, prospective study led by the Fred Hutchinson Cancer Center recommends that cancer patients receive SARS-CoV-2 mRNA vaccination three to four months after bone marrow transplant. The study found that early vaccination can provide crucial protection against severe COVID-19 in this vulnerable population.
A cutting-edge study in Mozambique found that the beta variant of SARS-CoV-2 was transmitted through regional migration from South Africa, while the delta variant entered mainly from the UK and India. The analysis also revealed that most introductions did not contribute to local spread.
A new commentary from infectious disease experts emphasizes the importance of continued masking in healthcare settings due to low evidence of efficacy and high transmission risks. Despite recent conflicting views, the authors argue that mask-wearing remains a crucial strategy for infection prevention.
A study of 14,400 febrile infants found that SARS-CoV-2 infection reduces the prevalence of urinary tract infections, bacteremia, and bacterial meningitis, particularly among infants aged 29 to 60 days. These findings suggest alternative management strategies for certain febrile infants testing positive for SARS-CoV-2.
A large study found that adults with obstructive sleep apnea were more likely to experience long-term symptoms of COVID-19 than those without the condition. Adults with both sleep apnea and COVID-19 were up to 75% more likely to develop long COVID, according to researchers.
A study of over 45,000 individuals found COVID-19-like symptoms without SARS-CoV-2 infection led to higher rates of depression and anxiety eight months post-symptom onset. Researchers also discovered that negative SARS-CoV-2 serologic test results did not mitigate this risk.
Researchers at the University of Illinois have identified strong correlations between SARS-CoV-2 cases and deaths, temperature, and latitude. The studies suggest that the virus is genetically encoded to exhibit seasonal behavior, which could be influenced by vaccine design.
MIT chemists develop rapid test to determine whether individuals have neutralizing antibodies against Covid-19, offering protection against future infections. The technique uses a fingerprint of sugar molecules to identify neutralizing antibodies in blood samples.
Researchers used computational tools and medical record analysis to investigate the effects of statin drugs on COVID-19 patients. They found that only certain statins, including simvastatin and atorvastatin, reduced mortality risk in COVID-19 patients, while others had no effect.
Researchers used AI tools to simplify a test for hepatitis C and SARS-CoV-2, achieving 97% accuracy for SARS-CoV-2 and 95% accuracy for the most prevalent version of hepatitis C. The team plans to refine the test, improve its ability to distinguish between strains, and potentially develop at-home tests in the future.
Patients with SARS-CoV-2 infection report cognitive deficits that are associated with post-COVID-19 condition (long COVID) symptoms. Researchers suggest a potential affective component in some patients, highlighting the need for further exploration of underlying reasons.
Researchers found that people who perceived cognitive difficulties during COVID were more likely to experience physical symptoms of long COVID. The study suggests a psychological component for lingering SARS-CoV-2 symptoms in some patients.